19.8.2024 15:16:14 CEST | Demant A/S |
Ledende medarbejderes transaktioner
Selskabsmeddelelse nr. 2024-13
19. august 2024
Bestyrelsesmedlemmers, direktionsmedlemmers og disses nærtståendes transaktioner med Demant-aktier
Indberetning i henhold til markedsmisbrugsforordningens artikel 19.
1.
Nærmere oplysninger om personen med ledelsesansvar/personen med nær tilknytning til denne
a)
Navn
Sisse Fjelsted Rasmussen
2.
Årsag til indberetningen
a)
Stilling/titel
Medlem af bestyrelsen
b)
Første indberetning/ændring
Første indberetning
3)
Nærmere oplysninger om udstederen, deltageren på markedet for emissionskvoter, auktionsplatformen, auktionsholderen eller den auktionstilsynsførende
a)
Navn
Demant A/S
b)
LEI-kode
213800RM6L9LN78BVA56
4.
Nærmere oplysninger om transaktionen/transaktionerne: Gentages for i) hver type instrument, ii) hver type transaktion, iii) hver dato og iv) hvert sted, hvor der er udført transaktioner
a)
Beskrivelse af det finansielle
instrument, instrumenttypen
Identifikationskode
Aktier
DK0060738599
b)
Transaktionens art
Køb
c)
Pris(er) og mængde(r)
Pris(er) Mængde(r)
DKK 271,70 pr. aktie 1.475 stk. aktier
Min. pris DKK 270,00
Max. pris DKK 272,00
d)
Aggregerede oplysninger:
– Aggregeret mængde
– Pris
Aggregeret mængde: 1.475 stk. aktier
Pris: DKK 271,70
e)
Dato for transaktionen
16. august 2024
f)
Sted for transaktionen
Nasdaq Copenhagen A/S
Kontaktpersoner:
Peter Pudselykke, Head of Investor Relations
Henrik Axel Lynge Buchter, Manager of External Communication
Telefon +45 3917 7300
www.demant.com
Kontakter
Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, heey@demant.com
Om Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Vedhæftninger
2024-13 Bestyrelsesmedlemmers, direktionsmedlemmers og disses nærtståendes transaktioner med Demant-aktier.pdf
19.8.2024 15:16:14 CEST | Demant A/S |
Managers' Transactions
Company announcement no 2024-13
19 August 2024
Transactions with Demant shares by Board of Directors,
Executive Board and their closely related parties
Notification on transactions pursuant to article 19 of the Market Abuse Regulation:
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Sisse Fjelsted Jacobsen
2.
Reason for the notification
a)
Position/status
Member of the Board of Directors
b)
Initial notification/amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
a)
Name
Demant A/S
b)
LEI
213800RM6L9LN78BVA56
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial
instrument, type of instrument
Identication code
Shares
DK0060738599
b)
Nature of the transaction
Purchase
c)
Price(s) and volume(s)
Price Volume
DKK 271.70 1,475 shares
Minimum price DKK 270.00
Maximum price DKK 272.00
d)
Aggregated information:
– Aggregated volume
– Price
1,475 shares
DKK 271.70
e)
Date of the transaction
16 August 2024
f)
Place of the transaction
Nasdaq Copenhagen A/S
Contacts:
Peter Pudselykke, Head of Investor Relations
Henrik Axel Lynge Buchter, Manager of External Communication
Phone +45 3917 7300
www.demant.com
Contacts
Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, heey@demant.com
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Attachments
2024-13 Board of Directors, Executive Board and closely related parties transactions with Demant shares.pdf
